Adipose-Derived Cell Therapy in Atlanta
Unlock powerful regenerative cells from your body's own adipose tissue for advanced musculoskeletal healing. Adipose-derived therapy delivers concentrated stem cells, growth factors, and regenerative proteins harvested from fat tissue directly to damaged joints, tendons, and ligaments. This minimally invasive cellular treatment yields high cell counts with easier collection than bone marrow. It is used in osteoarthritis, chronic tendon injuries and cartilage damage, where the evidence is still developing. When you need cellular healing capacity with minimal discomfort, adipose therapy is delivered with ultrasound-guided precision.

Abundant Cells.
Powerful Healing.
At Paragon Sports Medicine, we harness one of your body's richest sources of regenerative cells – adipose tissue. Adipose-derived stem cell therapy accesses mesenchymal stem cells (MSCs) from fat tissue, which contains significantly higher stem cell concentrations than bone marrow and can be harvested through a simple, minimally invasive mini-liposuction procedure. These adipose-derived stem cells (ADSCs) can differentiate into cartilage, bone, and tendon cells while releasing powerful growth factors including VEGF, HGF, IGF-1, and bFGF that promote tissue repair, reduce inflammation, and support regeneration. The stromal vascular fraction (SVF) isolated from adipose tissue contains not only stem cells but also pericytes, endothelial cells, and bioactive proteins that work synergistically to restore damaged musculoskeletal tissue. For patients seeking cellular regeneration with easier, less invasive harvesting than bone marrow aspiration, adipose therapy provides exceptional healing capacity.

The Science Behind
Adipose Regeneration
Adipose-derived therapy delivers concentrated stem cells and regenerative factors that rebuild damaged tissue:
High-Yield Stem Cell Harvest
Adipose tissue is a richer per-volume source of these cells than bone marrow. Reported yields vary widely across published methods, and collection is minimally invasive.
How These Cells Behave
In laboratory studies, adipose-derived stem cells can differentiate into cartilage, bone and tendon cells. What that means for any individual patient is still being studied.
Potent Growth Factor Release
ADSCs secrete VEGF (vascularization), HGF (tissue repair), IGF-1 (cell growth), bFGF (healing), and TGF-β (matrix production) for comprehensive tissue restoration.
Anti-Inflammatory Modulation
Stem cells possess immunomodulatory properties that reduce chronic inflammation, create optimal healing environments, and support long-term tissue health.
Paracrine Signaling & Tissue Support
Beyond direct differentiation, adipose cells release bioactive molecules that recruit native stem cells, enhance cellular activity, and orchestrate the entire regeneration cascade.


Cellular Healing for
Diverse Conditions
Adipose-derived therapy is used for joint degeneration, chronic soft tissue injuries, and inflammatory conditions. Fat tissue is a rich source of mesenchymal cells, and the harvest is less invasive than bone marrow aspiration. It is generally considered where tissue damage is significant, degenerative changes are advanced, or previous treatments have not given lasting relief. Unlike platelet therapies, it delivers mesenchymal cells as well as growth factors. Whether adipose therapy or a platelet-based treatment makes more sense for you is a judgement Dr. Garten will make from your examination and imaging.
Adipose-derived therapy is studied in: Osteoarthritis and joint degeneration, Chronic tendon and ligament injuries, Cartilage defects and soft tissue damage. The evidence in these conditions is still developing and outcomes vary.

Osteoarthritis & joint degeneration
Knee, hip, shoulder, and ankle arthritis where adipose stem cells can differentiate into cartilage cells and reduce inflammatory joint damage.

Chronic tendon & ligament injuries
Tennis elbow, Achilles tendinopathy, rotator cuff tears, plantar fasciitis, ligament sprains, and soft tissue injuries requiring cellular regeneration.
%20.avif)
Cartilage defects & soft tissue damage
Cartilage loss, meniscal tears, labral tears, and degenerative conditions where stem cell differentiation can restore tissue structure and function.
Your Journey
to Cellular Recovery
Harvest Site Preparation
You'll be positioned comfortably for access to the adipose collection site (typically abdomen or flanks). The area is cleaned, sterilized, and local anesthesia is administered to ensure comfort during the mini-liposuction procedure.
Adipose Tissue Collection
Using a small cannula, Dr. Garten performs a mini-liposuction to collect adipose tissue. The procedure is well-tolerated under local anesthesia and typically takes 15-20 minutes. Only a small amount of fat is needed (typically 30-60cc).
Cellular Processing & Concentration
Your adipose tissue is processed to isolate the stromal vascular fraction (SVF) containing stem cells, growth factors, and regenerative proteins. Processing methods concentrate the therapeutic cells while removing unnecessary components. This takes 30-45 minutes.
Ultrasound-Guided Injection
Using real-time musculoskeletal ultrasound, Dr. Garten precisely injects the concentrated adipose-derived cells directly into damaged tissue – whether joint, tendon, or ligament – ensuring maximum cellular delivery for optimal regeneration.
Recovery & Regeneration Protocol
You'll receive activity modification guidelines, recovery strategies, and a phased rehabilitation plan optimized for cellular regeneration timelines. Follow-up assessments track your tissue healing progress over subsequent months.

Your Cellular Regeneration Timeline
Adipose therapy initiates a biological regeneration process that unfolds over several months. Stem cells require time to differentiate, proliferate, and rebuild tissue. Understanding this timeline helps set realistic expectations.
Precision Expertise. Advanced Cellular Medicine.
Adipose-derived therapy requires specialized technique, proper processing protocols, and comprehensive understanding of cellular regeneration. Success depends on critical factors that distinguish expert care:
With over two decades of regenerative medicine experience and advanced training in cellular therapies, Dr. Garten brings elite expertise to every adipose procedure. His comprehensive approach gives you the best opportunity for meaningful functional restoration.

Choosing the Right Regenerative Approach

Adipose vs. BMAC
Key differences: Both provide mesenchymal stem cells but from different sources. Adipose tissue offers significantly higher stem cell yield (100-1000x more per volume) and easier, less invasive harvesting with minimal discomfort. Bone marrow may demonstrate stronger bone-forming and cartilage-forming potential for certain conditions. Adipose is often preferred when high cell numbers are desired with minimal procedural discomfort. Dr. Garten selects the optimal source based on your specific condition and treatment goals.
Adipose vs. PRP
When adipose is preferred: PRP delivers platelets and growth factors but no stem cells capable of regenerating lost tissue. Adipose therapy is chosen when cellular regeneration is required – cartilage loss, severe tendon damage, or conditions where tissue must be rebuilt. For moderate injuries, PRP may suffice. For severe degeneration requiring stem cells, adipose provides cellular capacity PRP cannot deliver.
Adipose vs. Surgery
Regenerative alternative: Adipose therapy is delivered as an injection. It does not involve a surgical incision, general anesthesia, or implanted hardware, and it does not close off future surgical options. Some conditions still require surgery, and Dr. Garten will give you an honest assessment of whether adipose therapy is appropriate for yours.
Combination Therapies
Synergistic approach: Adipose therapy can be combined with PRP for enhanced results – stem cells provide regenerative capacity while platelets create optimal growth environments. Some patients benefit from sequential treatments (adipose first for cellular regeneration, then PRP to support maturation) or combination injection. Dr. Garten designs personalized protocols based on condition complexity.
Abundant Stem Cell Yield
Adipose tissue is a richer per-volume source of these cells than bone marrow. Reported yields vary widely across published methods, and the cells are collected in a single minimally invasive harvest.
Minimally Invasive Collection
Mini-liposuction under local anesthesia is significantly less invasive and more comfortable than bone marrow aspiration. Most patients experience minimal discomfort during and after harvest, with faster recovery at the collection site.
Potent Growth Factor Profile
Adipose cells release powerful growth factors (VEGF, HGF, IGF-1, bFGF, TGF-β) that promote vascularization, reduce inflammation, stimulate cellular activity, and support comprehensive tissue repair.
Autologous Safety
Using only your own cells eliminates risks of rejection, disease transmission, or allergic reaction. The autologous nature provides excellent safety with minimal risk profile.
Surgical Alternative
For many conditions – particularly osteoarthritis, cartilage defects, and chronic tendon tears – adipose therapy offers effective regenerative treatment without surgical trauma, lengthy rehabilitation, or permanent anatomical changes, while preserving future treatment options.
The Adipose Advantage

Adipose Therapy:
Your Questions, Answered
Adipose tissue is collected through a mini-liposuction procedure performed under local anesthesia in our office. The harvest site (typically abdomen or flanks) is numbed completely, and most patients report minimal discomfort during the procedure – often describing only pressure or tugging sensations. The procedure takes 15-20 minutes. Afterward, the harvest site may feel sore similar to post-workout muscle soreness, with possible bruising or mild swelling for 3-5 days. Most patients find adipose collection significantly more comfortable than bone marrow aspiration and return to normal activities quickly. Only a small amount of fat is needed (30-60cc), so there's minimal cosmetic change at the harvest site.
Only a small amount of adipose tissue is required – typically 30-60 milliliters (approximately 2-4 tablespoons). Because fat tissue contains such high concentrations of stem cells (100-1000x more than bone marrow per volume), we can obtain millions of regenerative cells from minimal fat harvest. This small volume is collected through a tiny incision and causes minimal cosmetic change. Nearly all patients have sufficient adipose tissue for the procedure, regardless of body type. Even individuals with low body fat typically have adequate subcutaneous fat in the abdomen or flanks for successful stem cell harvest.
Both adipose and bone marrow provide mesenchymal cells alongside growth factors, but they differ in several ways. Adipose tissue is a richer per-volume source, with reported yields varying widely across published methods, and collection is less invasive than bone marrow aspiration. The growth factor profiles differ: adipose preparations have been reported to contain higher levels of VEGF and HGF, while bone marrow has been studied more in bone and cartilage settings. What either means for an individual patient is still being studied. Dr. Garten selects the source based on your condition, your imaging and your goals.
Where patients respond, improvement can last, though how long varies with the condition treated and the individual. Many patients experience sustained improvement for multiple years as regenerated tissue functions biologically. Durability depends on condition severity, age, activity level, biomechanics, ongoing degenerative processes, and rehabilitation adherence. Adipose therapy doesn't stop aging or prevent future injury, but regenerated tissue can provide meaningful long-term functional improvement. Some patients may eventually require additional treatment if degeneration progresses, though regenerated tissue often demonstrates better resilience than untreated degenerative tissue. Long-term outcomes continue to be studied as adipose therapy represents evolving advancement in regenerative medicine.
Most patients receive a single adipose treatment to initiate cellular regeneration. Depending on condition severity and initial response, some may benefit from a second treatment 6-12 months later. Unlike PRP series, adipose therapy typically isn't performed repeatedly due to the cellular nature of treatment and extended regeneration timeline required for stem cells to differentiate and produce tissue. Dr. Garten assesses your response through clinical evaluation and potentially imaging to determine if additional treatment is warranted. Some patients combine initial adipose therapy with subsequent PRP treatments to support the regeneration process without additional fat harvest.
Success rates vary based on the condition treated, severity, patient age, and individual factors. Published outcomes vary widely and no reliable pooled success rate exists. Factors associated with better outcomes include younger age, less severe degeneration, good overall health, appropriate patient selection, and rehabilitation adherence. Adipose therapy tends to be most effective for moderate osteoarthritis, cartilage defects, and chronic tendon injuries where viable tissue remains that can respond to cellular signals. Advanced bone-on-bone arthritis with complete cartilage loss may have lower success rates. Dr. Garten provides realistic expectations based on your specific condition during consultation.
For many patients with moderate-to-severe osteoarthritis, cartilage damage, or chronic tendon tears, adipose therapy is one option some patients consider before surgery. Whether it is appropriate, and what it may achieve, is a clinical decision made after examination and imaging. Success depends on degeneration severity, remaining tissue quality, and individual regenerative capacity. Patients with some remaining cartilage and earlier-stage disease tend to achieve better outcomes. Those with complete cartilage loss or very advanced degeneration may still require surgery, though adipose therapy can be attempted first without compromising future surgical options. Allowing patients to delay surgical intervention.
Adipose therapy costs reflect the specialized procedure, processing equipment, sterile consumables, extended procedure time, and cellular therapy expertise required. Costs vary depending on condition complexity and whether combination therapies are used. Our office provides transparent pricing during consultation. While adipose therapy represents an investment, many patients find it cost-effective compared to ongoing pain management, repeated treatments, or surgical intervention with associated costs and recovery time. We provide documentation for HSA/FSA reimbursement.
Like most regenerative medicine procedures, adipose-derived stem cell therapy is not typically covered by insurance and is considered out-of-pocket expense. Insurance companies generally classify autologous cellular therapies as investigational despite growing clinical evidence. Our office provides itemized documentation and procedure codes for HSA/FSA accounts or potential partial reimbursement submission, though coverage is not guaranteed. We recommend contacting your insurance provider to inquire about any coverage for autologous adipose-derived cellular procedures.
Yes, adipose therapy is often combined with other regenerative treatments for synergistic effect. Common combinations include:
Adipose + BMAC: Different MSC sources may complement each other for complex conditions
Adipose followed by PRP: Initial adipose for cellular regeneration, then PRP 3-6 months later to support tissue maturation
Adipose + Peptide Therapy: Systemic peptides optimize healing capacity and cellular activity
Adipose + Physical Therapy: Essential for tissue maturation, load tolerance, and functional restoration
Dr. Garten designs personalized treatment protocols that may incorporate multiple modalities to optimize your regenerative outcome.
Ideal candidates typically have moderate-to-severe osteoarthritis, cartilage defects, chronic tendon injuries, or degenerative conditions where cellular regeneration is beneficial and conservative treatments have been insufficient. You may be a good candidate if you have knee/hip/shoulder arthritis with remaining cartilage, tendinopathy or tendon tears, ligament injuries, cartilage damage, or conditions requiring stem cell therapy. You're likely NOT a good candidate if you have active infection, blood clotting disorders, complete bone-on-bone arthritis with severe deformity, unrealistic expectations, or unwillingness to follow extended rehabilitation protocols. Dr. Garten conducts comprehensive evaluation including clinical examination, imaging review, and discussion of goals to determine if adipose therapy is appropriate for your specific situation.
Adipose tissue is collected through a mini-liposuction procedure performed under local anesthesia in our office. The harvest site (typically abdomen or flanks) is numbed completely, and most patients report minimal discomfort during the procedure – often describing only pressure or tugging sensations. The procedure takes 15-20 minutes. Afterward, the harvest site may feel sore similar to post-workout muscle soreness, with possible bruising or mild swelling for 3-5 days. Most patients find adipose collection significantly more comfortable than bone marrow aspiration and return to normal activities quickly. Only a small amount of fat is needed (30-60cc), so there's minimal cosmetic change at the harvest site.
Only a small amount of adipose tissue is required – typically 30-60 milliliters (approximately 2-4 tablespoons). Because fat tissue contains such high concentrations of stem cells (100-1000x more than bone marrow per volume), we can obtain millions of regenerative cells from minimal fat harvest. This small volume is collected through a tiny incision and causes minimal cosmetic change. Nearly all patients have sufficient adipose tissue for the procedure, regardless of body type. Even individuals with low body fat typically have adequate subcutaneous fat in the abdomen or flanks for successful stem cell harvest.
Both adipose and bone marrow provide mesenchymal cells alongside growth factors, but they differ in several ways. Adipose tissue is a richer per-volume source, with reported yields varying widely across published methods, and collection is less invasive than bone marrow aspiration. The growth factor profiles differ: adipose preparations have been reported to contain higher levels of VEGF and HGF, while bone marrow has been studied more in bone and cartilage settings. What either means for an individual patient is still being studied. Dr. Garten selects the source based on your condition, your imaging and your goals.
Where patients respond, improvement can last, though how long varies with the condition treated and the individual. Many patients experience sustained improvement for multiple years as regenerated tissue functions biologically. Durability depends on condition severity, age, activity level, biomechanics, ongoing degenerative processes, and rehabilitation adherence. Adipose therapy doesn't stop aging or prevent future injury, but regenerated tissue can provide meaningful long-term functional improvement. Some patients may eventually require additional treatment if degeneration progresses, though regenerated tissue often demonstrates better resilience than untreated degenerative tissue. Long-term outcomes continue to be studied as adipose therapy represents evolving advancement in regenerative medicine.
Most patients receive a single adipose treatment to initiate cellular regeneration. Depending on condition severity and initial response, some may benefit from a second treatment 6-12 months later. Unlike PRP series, adipose therapy typically isn't performed repeatedly due to the cellular nature of treatment and extended regeneration timeline required for stem cells to differentiate and produce tissue. Dr. Garten assesses your response through clinical evaluation and potentially imaging to determine if additional treatment is warranted. Some patients combine initial adipose therapy with subsequent PRP treatments to support the regeneration process without additional fat harvest.
Success rates vary based on the condition treated, severity, patient age, and individual factors. Published outcomes vary widely and no reliable pooled success rate exists. Factors associated with better outcomes include younger age, less severe degeneration, good overall health, appropriate patient selection, and rehabilitation adherence. Adipose therapy tends to be most effective for moderate osteoarthritis, cartilage defects, and chronic tendon injuries where viable tissue remains that can respond to cellular signals. Advanced bone-on-bone arthritis with complete cartilage loss may have lower success rates. Dr. Garten provides realistic expectations based on your specific condition during consultation.
For many patients with moderate-to-severe osteoarthritis, cartilage damage, or chronic tendon tears, adipose therapy is one option some patients consider before surgery. Whether it is appropriate, and what it may achieve, is a clinical decision made after examination and imaging. Success depends on degeneration severity, remaining tissue quality, and individual regenerative capacity. Patients with some remaining cartilage and earlier-stage disease tend to achieve better outcomes. Those with complete cartilage loss or very advanced degeneration may still require surgery, though adipose therapy can be attempted first without compromising future surgical options. Allowing patients to delay surgical intervention.
Adipose therapy costs reflect the specialized procedure, processing equipment, sterile consumables, extended procedure time, and cellular therapy expertise required. Costs vary depending on condition complexity and whether combination therapies are used. Our office provides transparent pricing during consultation. While adipose therapy represents an investment, many patients find it cost-effective compared to ongoing pain management, repeated treatments, or surgical intervention with associated costs and recovery time. We provide documentation for HSA/FSA reimbursement.
Like most regenerative medicine procedures, adipose-derived stem cell therapy is not typically covered by insurance and is considered out-of-pocket expense. Insurance companies generally classify autologous cellular therapies as investigational despite growing clinical evidence. Our office provides itemized documentation and procedure codes for HSA/FSA accounts or potential partial reimbursement submission, though coverage is not guaranteed. We recommend contacting your insurance provider to inquire about any coverage for autologous adipose-derived cellular procedures.
Yes, adipose therapy is often combined with other regenerative treatments for synergistic effect. Common combinations include:
Adipose + BMAC: Different MSC sources may complement each other for complex conditions
Adipose followed by PRP: Initial adipose for cellular regeneration, then PRP 3-6 months later to support tissue maturation
Adipose + Peptide Therapy: Systemic peptides optimize healing capacity and cellular activity
Adipose + Physical Therapy: Essential for tissue maturation, load tolerance, and functional restoration
Dr. Garten designs personalized treatment protocols that may incorporate multiple modalities to optimize your regenerative outcome.
Ideal candidates typically have moderate-to-severe osteoarthritis, cartilage defects, chronic tendon injuries, or degenerative conditions where cellular regeneration is beneficial and conservative treatments have been insufficient. You may be a good candidate if you have knee/hip/shoulder arthritis with remaining cartilage, tendinopathy or tendon tears, ligament injuries, cartilage damage, or conditions requiring stem cell therapy. You're likely NOT a good candidate if you have active infection, blood clotting disorders, complete bone-on-bone arthritis with severe deformity, unrealistic expectations, or unwillingness to follow extended rehabilitation protocols. Dr. Garten conducts comprehensive evaluation including clinical examination, imaging review, and discussion of goals to determine if adipose therapy is appropriate for your specific situation.
Schedule a
consultation
We don't just treat injuries – we help regenerate tissue and unlock your body's full potential. Whether you're facing joint degeneration, chronic soft tissue damage, or seeking cellular regeneration with minimal invasiveness, our programs combine clinical expertise, current cellular biology, and carefully selected protocols.
Our comprehensive approach integrates advanced diagnostics, precise ultrasound-guided delivery, personalized rehabilitation, and recovery optimization to support your body's regenerative capacity at every stage. Cellular healing isn't accidental – it's intentional.
Adipose and bone marrow derived cell therapies are not FDA approved for the treatment of any orthopedic condition. Their use here is based on clinical judgment and the current published evidence, which is still developing. Individual results vary.
Schedule a
consultation
We don't just treat injuries – we help regenerate tissue and unlock your body's full potential. Whether you're facing joint degeneration, chronic soft tissue damage, or seeking cellular regeneration with minimal invasiveness, our programs combine clinical expertise, current cellular biology, and carefully selected protocols.
Our comprehensive approach integrates advanced diagnostics, precise ultrasound-guided delivery, personalized rehabilitation, and recovery optimization to support your body's regenerative capacity at every stage. Cellular healing isn't accidental – it's intentional.
Adipose and bone marrow derived cell therapies are not FDA approved for the treatment of any orthopedic condition. Their use here is based on clinical judgment and the current published evidence, which is still developing. Individual results vary.